NCT03961854View on ClinicalTrials.gov

Lactobacillus Johnsonii in Children and Adolescents With T1D

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 10, 2019

Primary Completion Date

March 1, 2026

Study Completion Date

March 11, 2026

Conditions
Type 1 Diabetes (T1D)
Interventions
DRUG

L. johnsonii Probiotic

Participants will consume one capsule of L. johnsonii probiotic daily for 24 weeks.

DRUG

Placebo Capsule

Participants will consume one capsule of placebo capsule of dried skim milk daily for 24 weeks.

Trial Locations (1)

32610

UF Clinical Research Center, Gainesville

Sponsors
All Listed Sponsors
collaborator

Juvenile Diabetes Research Foundation

OTHER

lead

University of Florida

OTHER